Collectively, these studies verified that tumors which induce cachexia in vivo because of STK11/LKB1 silencing display changes in their tumor immune landscapes similar to observations made by other groups in NSCLC tumors enriched for STK11/LKB1 alterations (11). The gene discussed is STK11; the disease is non-small cell lung carcinoma.